Nasdaq · Common stock
Ascendis Pharma A/S (ASND)
$245.15 +$1.78 (+0.73%)
- Day’s range
- $243.35–$246.40
- Volume
- 545,004
ASND price history
ASND closed at $245.15 on Oct. 26, 2026. Over the past year, its daily close ranged from $205.81 on June 8, 2026 to $277.18 on July 8, 2026.
Data table: ASND daily closes, the past year
| Date | Close |
|---|---|
| Oct. 26, 2026 | $245.15 |
| Oct. 23, 2026 | $243.37 |
| Oct. 22, 2026 | $242.99 |
| Oct. 21, 2026 | $238.90 |
| Oct. 20, 2026 | $234.33 |
| Oct. 19, 2026 | $229.95 |
| Oct. 16, 2026 | $225.25 |
| Oct. 15, 2026 | $226.62 |
| Oct. 14, 2026 | $227.00 |
| Oct. 13, 2026 | $223.21 |
| Oct. 12, 2026 | $227.00 |
| Oct. 9, 2026 | $229.23 |
| Oct. 8, 2026 | $222.69 |
| Oct. 7, 2026 | $228.41 |
| Oct. 6, 2026 | $226.05 |
| Oct. 5, 2026 | $228.03 |
| Oct. 2, 2026 | $227.87 |
| Oct. 1, 2026 | $227.31 |
| Sept. 30, 2026 | $227.83 |
| Sept. 29, 2026 | $228.07 |
| Sept. 28, 2026 | $230.05 |
| Sept. 25, 2026 | $225.60 |
| Sept. 24, 2026 | $230.70 |
| Sept. 23, 2026 | $223.13 |
| Sept. 22, 2026 | $237.57 |
| Sept. 21, 2026 | $237.59 |
| Sept. 18, 2026 | $236.72 |
| Sept. 17, 2026 | $239.04 |
| Sept. 16, 2026 | $247.69 |
| Sept. 15, 2026 | $239.77 |
| Sept. 14, 2026 | $264.92 |
| Sept. 11, 2026 | $263.52 |
| Sept. 10, 2026 | $261.23 |
| Sept. 9, 2026 | $260.81 |
| Sept. 8, 2026 | $270.09 |
| Sept. 4, 2026 | $270.56 |
| Sept. 3, 2026 | $271.12 |
| Sept. 2, 2026 | $267.31 |
| Sept. 1, 2026 | $260.25 |
| Aug. 31, 2026 | $263.04 |
| Aug. 28, 2026 | $247.91 |
| Aug. 27, 2026 | $249.36 |
| Aug. 26, 2026 | $250.25 |
| Aug. 25, 2026 | $252.99 |
| Aug. 24, 2026 | $251.95 |
| Aug. 21, 2026 | $253.29 |
| Aug. 20, 2026 | $254.81 |
| Aug. 19, 2026 | $259.62 |
| Aug. 18, 2026 | $248.85 |
| Aug. 17, 2026 | $247.40 |
| Aug. 14, 2026 | $248.50 |
| Aug. 13, 2026 | $246.23 |
| Aug. 12, 2026 | $255.46 |
| Aug. 11, 2026 | $254.57 |
| Aug. 10, 2026 | $255.62 |
| Aug. 7, 2026 | $255.41 |
| Aug. 6, 2026 | $249.85 |
| Aug. 5, 2026 | $244.20 |
| Aug. 4, 2026 | $244.59 |
| Aug. 3, 2026 | $243.45 |
| July 31, 2026 | $243.91 |
| July 30, 2026 | $251.07 |
| July 29, 2026 | $252.05 |
| July 28, 2026 | $254.44 |
| July 27, 2026 | $253.42 |
| July 24, 2026 | $253.86 |
| July 23, 2026 | $252.66 |
| July 22, 2026 | $251.93 |
| July 21, 2026 | $255.20 |
| July 20, 2026 | $251.76 |
| July 17, 2026 | $261.00 |
| July 16, 2026 | $259.80 |
| July 15, 2026 | $268.57 |
| July 14, 2026 | $265.57 |
| July 13, 2026 | $265.22 |
| July 10, 2026 | $270.45 |
| July 9, 2026 | $275.43 |
| July 8, 2026 | $277.18 |
| July 7, 2026 | $266.97 |
| July 6, 2026 | $267.92 |
| July 2, 2026 | $274.50 |
| July 1, 2026 | $267.79 |
| June 30, 2026 | $266.72 |
| June 29, 2026 | $263.70 |
| June 26, 2026 | $260.75 |
| June 25, 2026 | $261.58 |
| June 24, 2026 | $238.01 |
| June 23, 2026 | $238.59 |
| June 22, 2026 | $228.00 |
| June 18, 2026 | $230.83 |
| June 17, 2026 | $231.15 |
| June 16, 2026 | $231.20 |
| June 15, 2026 | $223.29 |
| June 12, 2026 | $218.06 |
| June 11, 2026 | $215.60 |
| June 10, 2026 | $209.79 |
| June 9, 2026 | $213.23 |
| June 8, 2026 | $205.81 |
| June 5, 2026 | $210.45 |
| June 4, 2026 | $218.84 |
| June 3, 2026 | $216.79 |
| June 2, 2026 | $216.60 |
| June 1, 2026 | $218.82 |
| May 29, 2026 | $224.11 |
| May 28, 2026 | $237.47 |
| May 27, 2026 | $235.26 |
| May 26, 2026 | $239.65 |
| May 22, 2026 | $247.05 |
| May 21, 2026 | $247.51 |
| May 20, 2026 | $241.34 |
| May 19, 2026 | $237.98 |
| May 18, 2026 | $237.64 |
| May 15, 2026 | $240.50 |
| May 14, 2026 | $245.49 |
| May 13, 2026 | $243.58 |
| May 12, 2026 | $237.65 |
| May 11, 2026 | $238.67 |
| May 8, 2026 | $238.66 |
| May 7, 2026 | $246.14 |
| May 6, 2026 | $235.90 |
| May 5, 2026 | $225.28 |
| May 4, 2026 | $228.71 |
| May 1, 2026 | $220.93 |
| April 30, 2026 | $229.38 |
| April 29, 2026 | $220.28 |
| April 28, 2026 | $222.08 |
| April 27, 2026 | $226.66 |
| April 24, 2026 | $229.27 |
| April 23, 2026 | $225.00 |
| April 22, 2026 | $231.05 |
| April 21, 2026 | $240.29 |
| April 20, 2026 | $245.38 |
Key figures
- Average daily volume
- 703,966Past 3 months
- Market value
- $16.13B
- Dividend yield
- —
Price change
- 1 month
- +8.67%
- 3 months
- −3.43%
What Wall Street says about ASND
In the past 90 days, Wall Street firms published 16 rating or price-target actions on ASND: 1 downgrade, 3 new ratings, 2 reiterated ratings, 3 raised price targets and 7 lowered price targets.
| Action | Rating | |||
|---|---|---|---|---|
| Citigroup | Cuts target | Buy | $360 to $330 | |
| UBS | Assumes coverage | Buy | $307 to $269 | |
| Cantor Fitzgerald | Reiterates | Overweight | $300 | |
| Raymond James | Downgrade | Strong buy to Outperform | $287 | |
| Oppenheimer | Raises target | Outperform | $304 to $312 | |
| Morgan Stanley | Cuts target | Overweight | $275 to $273 | |
| Wedbush | Reiterates | Outperform | $327 | |
| B of A Securities | Cuts target | Buy | $306 to $304 | |
| HC Wainwright & Co. | Cuts target | Buy | $345 to $344 | |
| Jefferies | Cuts target | Buy | $333 to $330 | |
| Stifel | Cuts target | Buy | $328 to $326 | |
| HC Wainwright & Co. | Initiates coverage | Buy | $345 | |
| BMO Capital | Initiates coverage | Outperform | $319 | |
| Barclays | Cuts target | Overweight | $345 to $329 | |
| RBC Capital | Raises target | Outperform | $280 to $290 | |
| TD Cowen | Raises target | Buy | $325 to $341 |
Ratings and price targets are the firms’ own opinions, reported as published.
Not investment advice.
About Ascendis Pharma A/S Ordinary Share
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
- Employees
- 1,189
- Listed
- April 20, 2026
In WallStreetDigest editions
No WallStreetDigest article about ASND is on the site yet.